摘要 |
<p>According to the invention, a compound represented by the formula (I) (wherein A represents an aryl group or a monocyclic or dicyclic heterocyclic group, R<SUB>1</SUB> represents a halide, a nitro group, a substituted C<SUB>1-6</SUB> alkyl group, an amino group which may be substituted, a C<SUB>1-6</SUB> alkyloxycarbonyl group, an aryl group which may be substituted, a heterocyclic group or a heterocyclic carbonyl group, R<SUB>2</SUB> represents a hydrogen atom or a C<SUB>1-6</SUB> alkyl group, R<SUB>3</SUB> represents a C<SUB>1-6</SUB> alkyl group, R<SUB>4</SUB>, R<SUB>5</SUB> and R<SUB>6</SUB> each represent a hydrogen atom, R<SUB>7</SUB> represents a C<SUB>1-6</SUB> alkyl group, m represents 1 or 2 and n represents 1) or a pharmacologically acceptable salt thereof or a solvate thereof is provided. This compound is a novel lincomycin derivative having a strong activity against resistant pneumococcal strains. Further, this compound can be used as an antibacterial agent and is useful for preventing or treating bacterial infection. (I)</p> |
申请人 |
MEIJI SEIKA KAISHA, LTD.;UMEMURA, EIJIROU;WAKIYAMA, YOSHINARI;UEDA, KAZUTAKA;KUMURA, KOU;NATSUME, SATOMI;WATANABE, TAKASHI;YAMAMOTO, MIKIO;KAJI, CHIZUKO;AJITO, KEIICHI |
发明人 |
UMEMURA, EIJIROU;WAKIYAMA, YOSHINARI;UEDA, KAZUTAKA;KUMURA, KOU;NATSUME, SATOMI;WATANABE, TAKASHI;YAMAMOTO, MIKIO;KAJI, CHIZUKO;AJITO, KEIICHI |